A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : IgG2 / immunoglobulin G2

[Related PubMed/MEDLINE]
Total Number of Papers: 72
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   IgG2  (>> Co-occurring Abbreviation)
Long Form:   immunoglobulin G2
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 M2 Macrophage Subpopulations in Glomeruli Are Associated With the Deposition of IgG Subclasses and Complements in Primary Membranous Nephropathy. C4d, GBM, IgG1, IgG3, PMN
2021 Relation between anti-Porphyromonas gingivalis antibody titers and HLA-DRB1 neutral alleles in individuals with rheumatoid arthritis. ACPA, IgG1, N/N, P. gingivalis, PD, RA, SE
2020 Extraction and purification of beta-glucanase from bovine rumen fungus Trichoderma reesei and its effect on performance, carcass characteristics, microbial flora, plasma biochemical parameters, and immunity in a local broiler hybrid Golpayegan-Ross. FCR, HDL, IgG1, IgM1, LDL, NSPs
2020 Immunoglobulin G1 Antibodies Against Phosphorylcholine Are Associated With Protection in Systemic Lupus Erythematosus and Atherosclerosis: Potential Underlying Mechanisms. anti-PCs, CI, CVD, IgG1, OR, SLE, SLEDAI, SLICC
2020 Treatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products. IVIG, KD
2019 Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy. CR
2017 Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis. ---
2016 Brodalumab for the treatment of psoriasis. ---
2016 Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction. LDL-C, PCSK9
10  2016 Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients. HER2, IgG, IgM, TAA
11  2016 Placental transfer of anti-group B Streptococcus immunoglobulin G antibody subclasses from HIV-infected and uninfected women to their uninfected infants. GBS, ST
12  2015 Enhanced Immune Response to DNA Vaccine Encoding Bacillus anthracis PA-D4 Protects Mice against Anthrax Spore Challenge. ELISA, IFN-gamma, IgM, PA
13  2015 Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab. CI, CTLA-4
14  2013 Development of a human antibody tolerant mouse model to assess the immunogenicity risk due to aggregated biotherapeutics. ADA, IgG
15  2013 The identification of free cysteine residues within antibodies and a potential role for free cysteine residues in covalent aggregation because of agitation stress. IgG1
16  2013 VEGFR2-targeted molecular imaging in the mouse embryo: an alternative to the tumor model. VEGFR2
17  2009 Acquired Glanzmann's thrombasthenia caused by glycoprotein IIb/IIIa autoantibodies of the immunoglobulin G1 (IgG1), IgG2 or IgG4 subclass: a study in six cases. GP, GT, IgG1
18  2009 Determination of Fab-hinge disulfide connectivity in structural isoforms of a recombinant human immunoglobulin G2 antibody. ---
19  2009 HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. HIV-1, Nef
20  2008 Kinesin motor domain of Leishmania donovani as a future vaccine candidate. IL-2, VL
21  2007 Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. GXM, IgG, mAbs
22  2007 Immunogenicity of Anaplasma marginale type IV secretion system proteins in a protective outer membrane vaccine. CTP
23  2006 Characterization of the opsonic and protective activity against Staphylococcus aureus of fully human monoclonal antibodies specific for the bacterial surface polysaccharide poly-N-acetylglucosamine. mAbs, PNAG
24  2005 Decreased levels of interleukin-12p40 in the serum of patients with Whipple's disease. IFN-gamma, IL, TNF-alpha, WD
25  2005 Identification of novel antigenic proteins in a complex Anaplasma marginale outer membrane immunogen by mass spectrometry and genomic mapping. OMP, OpAG2
26  2005 Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children. FcgammaR, MSP2, RBCs
27  2004 A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens. AIH, anti-LC1, anti-LKM1, FTCD
28  2004 Clinical evaluation and treatment of the adult patient with suspected primary immunodeficiency disease: a case analysis. ---
29  2004 Delineation of the role of platelet-activating factor in the immunoglobulin G2 antibody response. DC, IL-12, LAgP, PAF
30  2004 Dendritic cells stimulated with Actinobacillus actinomycetemcomitans elicit rapid gamma interferon responses by natural killer cells. GCF, IL-12, LAgP, LPS, mDCs
31  2004 Identification of IgG2-specific antigens in Mexican Anaplasma marginale strains. LP, PBMCs
32  2004 IgG subclass responses in childhood Helicobacter pylori duodenal ulcer: evidence of T-helper cell type 2 responses. IgGsc
33  2004 Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. IL-1beta
34  2003 Effect of vaccination with a recombinant fusion protein encoding an astacinlike metalloprotease (MTP-1) secreted by host-stimulated Ancylostoma caninum third-stage infective larvae. AS02
35  2003 Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice. DT, GXM, TT
36  2002 Biological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide. mAb
37  2002 Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype. HA, HI, mAbs, VN
38  2002 Monocyte differentiation in localized juvenile periodontitis is skewed toward the dendritic cell phenotype. LJP, MDDC, NP
39  2002 Recurrent variable region gene usage and somatic mutation in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae type 23F. ---
40  2001 Antibody responses of cattle immunized with the Tf190 adhesin of Tritrichomonas foetus. ---
41  2001 Down-regulated lymphoproliferation coincides with parasite maturation and with the collapse of both gamma interferon and interleukin-4 responses in a bovine model of onchocerciasis. IL-4, PBMC
42  2001 Non-redundant roles for interleukin-1 alpha and interleukin-1 beta in regulating human IgG2. AgP, IL, LAgP, PBL, PWM
43  2001 Non-Redundant Roles for Interleukin-1alpha and Interleukin-1beta in Regulating Human IgG2. AgP, IL, LAgP, PBL, PWM
44  2000 Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia. ---
45  2000 Cytophilic immunoglobulin responses to Plasmodium falciparum glutamate-rich protein are correlated with protection against clinical malaria in Dielmo, Senegal. ADCI, GLURP
46  2000 High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria. IgG
47  2000 Regulation of immunoglobulin G2 production by prostaglandin E(2) and platelet-activating factor. LJP, PAF
48  1999 Antiphosphorylcholine antibody levels are elevated in humans with periodontal diseases. PC
49  1999 Avidity as a determinant of the protective efficacy of human antibodies to pneumococcal capsular polysaccharides. ---
50  1999 Pathogenicity island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. beta-Gal
51  1998 CD4(+) T-lymphocyte and immunoglobulin G2 responses in calves immunized with Anaplasma marginale outer membranes and protected against homologous challenge. MSPs, PBMC
52  1998 CD4-immunoglobulin G2 protects Hu-PBL-SCID mice against challenge by primary human immunodeficiency virus type 1 isolates. HIV-1, LAI
53  1998 Involvement of antilipoarabinomannan antibodies in classical complement activation in tuberculosis. LAM
54  1997 Haemophilus somnus immunoglobulin binding proteins and surface fibrils. anti-DNP, HMW, IgBPs, OM
55  1997 Serum immunoglobulin G responses to various Actinobacillus actinomycetemcomitans serotypes in a young ethnographically heterogeneous periodontitis patient group. ---
56  1996 Hyper-immunoglobulin G2 production by B cells from patients with localized juvenile periodontitis and its regulation by monocytes. LJP, NP
57  1996 Immunoglobulin allotypes and immunoglobulin G subclass responses to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in early-onset periodontitis. EOP, LJP, RPP
58  1995 Immunoglobulin G2 antibodies promote neutrophil killing of Actinobacillus actinomycetemcomitans. LJP
59  1995 Unilateral cytomegalovirus retinitis in a patient with immunoglobulin G2 deficiency. CMV
60  1994 Haemophilus influenzae type D infection and IgG2 deficiency in a patient with chronic mucocutaneous candidiasis. ---
61  1994 Serum immunoglobulin G subclass concentrations in periodontally healthy and diseased individuals. AP, LJP, NP
62  1993 Immunoglobulin G subclasses in Crohn's disease with and without bowel resection. ---
63  1992 Complement activation by polyclonal immunoglobulin G1 and G2 antibodies against Staphylococcus aureus, Haemophilus influenzae type b, and tetanus toxoid. Hib, TT
64  1992 Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters. ---
65  1991 Regulation of the human T-cell response to Schistosoma japonicum egg antigen by concomitant cellular and humoral mechanisms in vitro. SEA
66  1990 Antiphospholipid antibody syndrome: immunologic and clinical aspects. ELISA, SLE
67  1990 Humoral immunity in the ewe. 1. The influence of adjuvancy and immunogenic substitution on immune reactivity following immunisation with protein antigens. BSA, IgG1, IgM, KLH, TNP
68  1990 Humoral immunity in the ewe. 2. The effect of pregnancy on the primary and secondary antibody response to protein antigen. BSA, IgG1, IgM
69  1990 Humoral immunity in the ewe. 3. The influence of adjuvants and immunisation regimes on immune reactivity in the breeding ewe and her progeny. IgG1, IgM
70  1985 Quantitation of bovine immunoglobulin G2 by a competitive fluorescence immunoassay. FIA, SRD
71  1978 The primary structure of a human immunoglobulin G2 (IgG2) pFc' fragment. ---
72  1977 Antibody response to rabies virus in Syrian hamsters. RV